Exhibit 16.1
April 13, 2017
Securities and Exchange Commission
100 F Street, N.W.
Washington, D.C. 20549
Re: Dthera Sciences
We have read the statements of Dthera Sciences pertaining to our firm included under Item 4.02 of Form 8-K dated April 7, 2017 and agree with such statements as they pertain to our firm.
/s/ Sadler, Gibb & Associates, LLC
SADLER, GIBB & ASSOCIATES, LLC
Salt Lake City, Utah
April 13, 2017